cbdMD Inc

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded by Caryn Dunayer on March 17, 2015 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.

Charlotte, North Carolina--(Newsfile Corp. - August 25, 2023) - The Pet Innovation Awards has announced that cbdMD, Inc. (NYSE American: YCBD), a highly trusted and recognized cannabidiol (CBD) brand, and its pet products brand, Paw CBD, have been honored with the prestigious "Dog Hip & Joint Product of the Year" award for their Hip+Joint Soft Chews in the 2023 awards program. Paw CBD's Hip+Joint Soft Chews provide essential comfort and care for dogs, supporting mobility and enhancing overall wellbeing.

Paw CBD Wins 2023 'Dog Hip & Joint Product of the Year' Pet Innovation Award

Charlotte, North Carolina--(Newsfile Corp. - August 22, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) today announced that its Board of Directors has suspended the monthly cash dividend payment on the Company's 8.0% Series A Cumulative Convertible Preferred Stock (the "Series A Preferred Stock") beginning with the month ending August 31, 2023, as the Company conserves cash in order to continue its efforts to increase sales, develop additional products, continue research and development and attempt to achieve profitability. The dividends on the Company's Series A Preferred Stock have been suspended until such time as the Board of directors deem that the Company has sufficient working capital to restore the payment of the dividends.

cbdMD, Inc. Suspends Monthly Dividend Payment on Its Series A Cumulative Convertible Preferred Stock

Washington, D.C.--(Newsfile Corp. - August 18, 2023) -  cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced its direct response to the Bicameral and Bipartisan Congressional RFI on FDA Regulation of CBD and urges FDA to provide regulatory clarity.

cbdMD Responds to Congressional Request for Information (RFI) on Regulation of CBD Products

Charlotte, North Carolina--(Newsfile Corp. - August 10, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator the leading CBD brands – including its flagship brand cbdMD, and its animal health brand Paw CBD, today announced our third quarter of fiscal 2023 results. For the third quarter of fiscal 2023 Net Loss improved to $1.7 million on sales of $6.1 million as compared to a $31.6 million Net Loss on sales of $8.6 million in the prior year comparative quarter.

cbdMD Demonstrates Strong Year-over-Year Performance, Significantly Reducing Net Loss by $30 Million

Charlotte, North Carolina--(Newsfile Corp. - August 7, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:30 p.m., Eastern Time, on Thursday August 10, 2023, to discuss the company's June 30, 2023 third quarter of fiscal 2023 financial results and business progress.

cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2023 Results

Charlotte, North Carolina--(Newsfile Corp. - August 3, 2023) - cbdMD (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced the launch of its hemp-derived Delta 9 THC + CBD gummies - UPLIFT, ELEVATE, and RELAX - the brand's first line designed to give you a specific strain-like experience. The new lineup is designed to create a personalized morning to night routine that makes it easier than ever for consumers to incorporate these products into their daily lives.

cbdMD Releases Tropical Hemp-derived THC + CBD Gummy Line to Elevate Consumer Wellness

Charlotte, North Carolina--(Newsfile Corp. - June 29, 2023) - cbdMD (NYSE American: YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced their e-commerce experience will now be powered by Shopify. cbdMD is committed to improve the customer experience holistically, which starts at the point of purchase.

cbdMD Announces Migration to E-Commerce Platform, Shopify

Charlotte, North Carolina--(Newsfile Corp. - June 22, 2023) - cbdMD (NYSE American: YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, is delighted to announce the appointment of Dr. Lucille Vega as their new medical advisor. This collaboration marks an exciting chapter for both parties, as they play a pivotal role in educating the public about the numerous benefits of CBD and cbdMD's commitment to quality and transparency.

cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega

cbdMD, Inc. (NYSE:YCBD ) Q2 2023 Earnings Conference Call May 15, 2023 4:15 PM ET Company Participants Brad Whitford - VP of Finance Ronan Kennedy - Interim Chief Executive Officer and Chief Financial Officer Sibyl Swift - Chief Science Officer & VP Regulatory Affairs Conference Call Participants Anthony Vendetti - Maxim Group Operator Good afternoon. Welcome to cbdMD's, Inc. March 31, 2023, Second Quarter of Fiscal '23 Earnings Call and Update.

cbdMD, Inc. (YCBD) Q2 2023 Earnings Call Transcript

Company reduces annualized SG and A expenses $24 million year over year Charlotte, North Carolina--(Newsfile Corp. - May 15, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator the leading CBD brands - including its flagship brand cbdMD, and its animal health brand Paw CBD, today announced our second quarter of fiscal 2023 results. For the second quarter of fiscal 2023 GAAP Net Loss improved to $1.4 million on sales of $6.2 million as compared to a $5.0 million Net Loss on sales of $9.6 million in the prior year comparative quarter.

cbdMD Stabilizes Revenue and Significantly Improves Operating Results

Charlotte, North Carolina--(Newsfile Corp. - May 10, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:15 p.m., Eastern Time, on Monday, May 15, 2023, to discuss the company's March 31, 2023 second quarter of fiscal 2023 financial results and business progress.

cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2023 Results

Charlotte, North Carolina--(Newsfile Corp. - May 3, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced the closing of its previously announced underwritten public offering of 1,350,000 shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering before deducting underwriting discounts and commissions and offering expenses were approximately $2.8 million.

cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock

Charlotte, North Carolina--(Newsfile Corp. - April 30, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced the pricing of its previously announced underwritten public offering of 1,350,000 shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering are expected to be approximately $2.8 million before deducting underwriting discounts, commissions, and estimated offering expenses.

cbdMD Announces Pricing of $2.8 Million Underwritten Public Offering of Common Stock

Charlotte, North Carolina--(Newsfile Corp. - April 28, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading CBD companies, today announced it has commenced an underwritten public offering of shares of its common stock. All shares of common stock in the offering are to be sold by cbdMD.

cbdMD Announces Proposed Public Offering of Common Stock

Results from the canine clinical study suggest that cbdMD's proprietary blend promotes mobility in dogs Charlotte, North Carolina--(Newsfile Corp. - April 18, 2023) - cbdMD®, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the results from its canine clinical study conducted at Colorado State University. The clinical study explored the benefits of our core broad spectrum hemp extract in dogs, and the data suggests that daily consumption of the product positively impacted dogs' mobility.

cbdMD's Clinical Study Supports Improved Mobility in Dogs

Charlotte, North Carolina--(Newsfile Corp. - April 14, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) , a leading provider of high-quality CBD products, announced today that its board of directors on April 12, 2023 approved a ratio of one-for-forty five reverse stock split of the Company's issued and outstanding shares of common stock. The Company's shareholders previously approved the reverse stock split on February 16, 2023 and granted the board the authority to determine a final reverse split ratio.

cbdMD, Inc. Announces One-for-Forty Five Reverse Stock Split of Its Common Stock

cbdMD Enters the UK Market with Debut on Amazon UK, Offering High-Quality CBD Solutions for Wellness and Self-Care Charlotte, North Carolina--(Newsfile Corp. - April 12, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, announces the successful launch of its Novel Food validated premium hemp-derived CBD products on Amazon.co.uk in the United Kingdom ("Amazon UK"). cbdMD gummies, tinctures, and topicals are now available on Amazon UK and qualify for next day delivery through Amazon Prime.

cbdMD Expands its Reach to The United Kingdom with Launch on Amazon UK

CHARLOTTE, N.C.--(BUSINESS WIRE)---- $YCBD #NSF--New suite of products allows professionals from all walks of life to add CBD to their regimen without fear of failing a drug test for THC.

cbdMD™ Makes History Becoming the First CBD Brand to Achieve 3 NSF's Certified for Sport® Certifications

Charlotte, North Carolina--(Newsfile Corp. - February 16, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted, and widely recognized CBD companies, announces its General Counsel, Lance Blundell, and Chief Science Officer, Dr. Sibyl Swift, will be speaking on a panel at the Sports and Active Nutrition Summit, USA - Sponsored by Nutraingredients.

cbdMD to Present at NutraIngredients-USA's Sports and Active Nutrition Summit

cbdMD, Inc. (NYSE:YCBD ) Q4 2022 Earnings Conference Call February 13, 2022 4:15 PM ET Company Participants Brad Whitford - VP of Finance Ronan Kennedy - CFO and COO Kevin MacDermott - President Conference Call Participants Operator Good afternoon. Welcome to cbdMD Inc.'s December 31, 2022 First Quarter of Fiscal 2023 Earnings Call and Update.

cbdMD, Inc. (YCBD) Q4 2022 Earnings Call Transcript

Company continues to make headway despite challenging consumer environment.Charlotte, North Carolina--(Newsfile Corp. - February 13, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator the leading CBD brands – including its flagship brand cbdMD, and its animal health brand Paw CBD, today announced our first quarter of fiscal 2023 results. For the first quarter of fiscal 2023 Net Loss improved to $3.9 million on sales of $6.

cbdMD Posts $15 Million in Net Income Improvement over Prior Year Quarter

Charlotte, North Carolina--(Newsfile Corp. - February 13, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the closing of the return of its $1 million investment following the closing of the ADARA SPAC acquisition on February 10, 2023.

cbdMD Receives $1 Million Return of Capital Following Closing of Adara SPAC Transaction

Charlotte, North Carolina--(Newsfile Corp. - February 6, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Monday, February 13, 2023, to discuss the company's December 31, 2022 first quarter of fiscal 2023 financial results and business progress.CONFERENCE CALL DETAILSMonday, February 13, 2023, 4:15 p.m.

cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2023 Results

Leading CBD company comments on FDA declining to regulate the industry and calling on Congress to create new rulesCharlotte, North Carolina--(Newsfile Corp. - January 26, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted, and widely recognized CBD companies, announces their commitment to hold the FDA accountable for years of oversight regarding the establishment of safe regulatory frameworks appropriate for cannabinoids.

cbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent News

Charlotte, North Carolina--(Newsfile Corp. - January 11, 2023) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the appointment of Shannon Charles as Chief Marketing Officer. Shannon is a veteran in health and wellness with over a decade of success in the Natural Product Industry.

News for cbdMD Inc Stock (YCBD)